Meet us in... Chicago

The ASAIO 63rd Annual Conference will take place in Chicago from 21 through 24 June. It is organized by the American Society for Artificial Internal Organs, so it may not be an event where you’d expect to see LifeTec Group. But we’ll be there, and we look forward to meeting you in Chicago!

Biosimulator

LifeTec Group is best known for its development of the unique PhysioHeart™, also known as ‘the beating heart platform’:

PhysioHeart™

The PhysioHeart™ is an isolated autonomous beating heart model that approaches the in vivo situation as closely as conceivable.

It works with a real heart perfused with real blood, and it displays natural electrophysiological behavior, muscle contraction and heart valve behavior; it produces a physiological hemodynamic environment.

Until the moment when an Artificial Internal Organ actually reaches the patient, there’s a long process of research, development and training leading up to it. LifeTec Group can play an important role in this process, from idea phase right up to clinical studies: 

LifeTec Group can help researchers or idea owners move faster from idea to application. This speed is cost-reducing and also saves lab animals’ lives.

‘A heart, beating without a body’

Arend de Weger, Cardiothoracic Surgeon and keynote speaker in Chicago, will present a report on one of the recent developments and (new) applications of the ‘beating heart platform’: the combination of MRI scanner and PhysioHeart, of which Arend is co-developer. 

4D flow in MRI (vortex)
4D flow in MRI

One of the experiments that Arend de Weger will talk about is part of the PAPAVER project.

PAPAVER is the acronym for Progression in Image Analysis for Percutaneous Aortic Valve Replacement.

Within this project Pim van Ooij, researcher at the Amsterdam Medical Centre, is working on innovative software that can quickly reproduce the so-called 4D flow: the speed with which blood flows in three dimensions at any given moment.

‘Arteries and veins, without a body’

Noemi Vanerio will do an oral presentation about the insights she gained during the MUSICARE project. 

MUSICARE

The MUSICARE project* gathers industry, university and clinical professionals, creating a trans-sectoral and multidisciplinary network to face the main challenges in the cardiovascular field.

In this framework, the development of breakthrough technologies and the creation of new clinical solutions are combined with the shaping of young researchers with the final aim of having an impact on the cardiovascular field from scientific, educational and technological points of view.

 

Noemi Vanerio: “In my presentation “Ex Vivo Pathological Platform for Vascular Device Testing” I will talk about a new approach for long-term device testing, research and training purposes based on a pathological ex vivo blood vessel model that LifeTec Group is developing. In LifeTec’s vascular bioreactor platform (VABIO Platform), blood vessels are cultured under physiologic hemodynamic flows and pressures, and the pathology can be induced to mimic the real clinical conditions of a patient undergoing surgery. The platform allows then for the treatment of the diseased region through the implantation of medical devices such as stents and vascular grafts and for the long-term effect evaluation. I am really looking forward to going to Chicago to present our work and to share ideas at such an interesting conference.”

  • Noemi Vanerio | Incompany presentation
    Noemi Vanerio | Incompany presentation
    Noemi Vanerio | Incompany presentation
  • Noemi Vanerio | Incompany presentation @ LifeTec Group
    Noemi Vanerio | Incompany presentation @ LifeTec Group
    Noemi Vanerio | Incompany presentation @ LifeTec Group
  • Noemi Vanerio | research team meeting @ LifeTec Group
    Noemi Vanerio | research team meeting @ LifeTec Group
    Noemi Vanerio | research team meeting @ LifeTec Group
  • Noemi Vanerio | research team meeting @ LifeTec Group
    Noemi Vanerio | research team meeting @ LifeTec Group
    Noemi Vanerio | research team meeting @ LifeTec Group

R&D

LifeTec Group’s R&D Director Marco Stijnen will use this opportunity mainly to create new contacts and find fresh inspiration. This will help improve LifeTec Group’s services and gear them even more accurately to the needs of the researchers and developers of artificial internal organs, among others.

Marco Stijnen: “The ‘beating heart’ can also be regarded as an internal organ; if the organ fails, ventricular assist devices will be used to help the faltering heart. These pump devices act like artificial organs, so the studies into these pumps will also be presented at this conference. My visit to Chicago has two purposes: on the one hand to discover if there’s a need for our support on the pump side of things; on the other hand to see if other isolated organ models might be of value in the future, to support current scientists and future products.” 

Plan an appointment?

Should you be interested in exchanging ideas with Arend, Noemi or Marco while in Chicago, please contact our office manager Janneke Cuijpers. She will be more than happy to put you in touch with them, or plan an appointment for you during the conference. 

Director R&D

Marco Stijnen

R&D Engineer

Noemi Vanerio

Office Manager

Janneke Cuijpers

Relevant links and background

This work was supported by the European Commission within the Horizon 2020 Framework through the MSCA-ITN-ETN European Training Networks (project number 642458).

COLOFON
Musicare

©2017 LifeTecGroup.  Legal  Credits